Navegar por término MeSH "Factor VIII"

Mostrando ítems 1-2 de 2

BAY 81-8973 demonstrated efficacy, safety and joint status improvement in patients with severe haemophilia A in the LEOPOLD I extension for ?2 years

2020- Mahlangu, Johnny; López Fernández, María Fernanda; Santagostino, Elena; Lalezari, Shadan; Tseneklidou-Stoeter, Despina; [et al.]
Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trial

2019- Gruppo, Ralph; López Fernández, María Fernanda; Wynn, Tung T; Engl, Werner; Sharkhawy, Marlies; [et al.]